Aster DM Healthcare IPO GMP History
Aster DM Healthcare IPO has been listed on February 26, 2018 at a listing price of ₹183, against the issue price of ₹190 — a loss of ₹7 (-3.68%). The GMP peaked at ₹67.5 on 11 February 2018 and reached a low of ₹7.5 on 14 February 2018. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Aster DM Healthcare IPO raised ₹980.14 Cr. through its IPO at a price band of ₹180 to ₹190 per share, with a lot size of 78 shares. The IPO was open for subscription from 12 Feb 2018 to 15 Feb 2018.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 3:11 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 14 Feb 2018 | ₹ 7.5 | — | 4% | — | — |
| 13 Feb 2018 | ₹ 7.5 | — | 4% | — | — |
| 12 Feb 2018 | ₹ 7.5 | ▼ | 4% | — | — |
| 11 Feb 2018 | ₹ 67.5 | — | 36% | — | — |
| 10 Feb 2018 | ₹ 67.5 | — | 36% | — | — |
| 09 Feb 2018 | ₹ 67.5 | — | 36% | — | — |
| 08 Feb 2018 | ₹ 67.5 | — | 36% | — | — |
| 07 Feb 2018 | ₹ 67.5 | — | 36% | — | — |
| 06 Feb 2018 | ₹ 67.5 | — | 36% | — | — |
| 05 Feb 2018 | ₹ 67.5 | — | 36% | — | — |
Aster DM Healthcare IPO dates
Key dates from opening to listing. Today is 14 November.
- Open 12 Feb 2018
- Close 15 Feb 2018
- Allotment 22 Feb 2018
- Refund/credit 22 Feb 2018
- Listing 26 Feb 2018
Aster DM Healthcare IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹190 |
|---|---|
| GMP-based estimate (pre-listing) | ₹197 (+3.7%) |
| Listing gain / loss | −₹7 per share |
| Listing date | 26 Feb, 2018 |
| Actual listing price | ₹183 (-3.68%) |
Is Aster DM Healthcare IPO GMP reliable?
Grey market premium for Aster DM Healthcare IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Aster DM Healthcare IPO full review for a fundamentals-based assessment before making any grey market trades.
Aster DM Healthcare IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Aster DM Healthcare IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Aster DM Healthcare IPO
Aster DM Healthcare Limited is a healthcare provider with operations in the GCC states (UAE, Oman, Saudi Arabia, Qatar, Kuwait and Bahrain), India and the Philippines. Its promoters are Azad Moopen and Union Investments.
Its Indian operations are headquartered in Kochi, Kerala.
It operates across hospitals, clinics, pharmacies and other healthcare services.
The IPO was Rs 980.14 crore, with Rs 725.00 crore of fresh issue and Rs 255.14 crore of offer for sale, at Rs 190, the top of the Rs 180 to Rs 190 band. Most of the fresh money was for repaying debt and buying medical equipment.
Frequently asked
What is the GMP of Aster DM Healthcare IPO?
The current Grey Market Premium (GMP) of Aster DM Healthcare IPO is ₹ 7.5.
What is the Kostak Price of Aster DM Healthcare IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Aster DM Healthcare IPO is not available.
What is the Subject to Sauda Price of Aster DM Healthcare IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Aster DM Healthcare IPO?
Aster DM Healthcare IPO listed on February 26, 2018 at ₹183, against the issue price of ₹190 — a loss of -3.68%.
How did the GMP of Aster DM Healthcare IPO trend before listing?
The GMP of Aster DM Healthcare IPO was stable in its final days before listing. The GMP peaked at ₹67.5 on 11 February 2018. View the day-wise table above for the complete GMP history.
Explore Aster DM Healthcare IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
